What Conditions Is BetterLife Pharma Looking To Treat With Its Novel Therapeutics?

BetterLife Pharma Inc. (CSE: BETR) (OTCQB: BETRF) (FRA: NPAU) CEO Dr. Ahmad Doroudian, PhD, discusses the indications being investigated by the company for treatment, including major depressive disorder and cluster headaches.